Primary Recipient

DUQUESNE UNIVERSITY OF THE HOLY SPIRIT

Amount

$611,564.00

Award Date

5/28/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Molecularly targeted agents against receptor tyrosine kinases (RTK), particularly the antiangiogenic agents (AAs), have caused a paradigm shift in cancer chemotherapy. These agents target tumor angiogenic mechanisms (sprouting of new blood vessels) that a

Recipients Connected to Award

Recipient	Role	Amount
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT	Primary recipient	$451,056.00
UNIVERSITY OF OKLAHOMA	Sub-recipient	$160,508.00